To date, several studies have been conducted to evaluate the association between XRCC1 polymorphisms and thyroid cancer risk in different ethnic populations, but the results remain conflicting rather than conclusive [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26]. This evidence concerns the gene XRCC1 and thyroid gland carcinoma.